Kentistou, Katherine A. https://orcid.org/0000-0002-5816-664X
Lim, Brandon E. M.
Kaisinger, Lena R.
Steinthorsdottir, Valgerdur https://orcid.org/0000-0003-1846-6274
Sharp, Luke N. https://orcid.org/0009-0001-3657-5493
Patel, Kashyap A. https://orcid.org/0000-0002-9240-8104
Tragante, Vinicius https://orcid.org/0000-0002-8223-8957
Hawkes, Gareth https://orcid.org/0000-0002-3367-789X
Gardner, Eugene J. https://orcid.org/0000-0001-9671-1533
Olafsdottir, Thorhildur https://orcid.org/0000-0003-2003-9984
Wood, Andrew R. https://orcid.org/0000-0003-1726-948X
Zhao, Yajie https://orcid.org/0000-0002-2747-0219
Thorleifsson, Gudmar https://orcid.org/0000-0003-4623-9087
Day, Felix R. https://orcid.org/0000-0003-3789-7651
Ozanne, Susan E.
Hattersley, Andrew T. https://orcid.org/0000-0001-5620-473X
O’Rahilly, Stephen https://orcid.org/0000-0003-2199-4449
Stefansson, Kari https://orcid.org/0000-0003-1676-864X
Ong, Ken K.
Beaumont, Robin N. https://orcid.org/0000-0003-0750-8248
Perry, John R. B. https://orcid.org/0000-0001-6483-3771
Freathy, Rachel M. https://orcid.org/0000-0003-4152-2238
Funding for this research was provided by:
Wellcome Trust (WT220390)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD101669)
RCUK | Medical Research Council (MC_UU_00006/2)
Article History
Received: 13 April 2024
Accepted: 20 December 2024
First Online: 14 January 2025
Competing interests
: J.R.B.P. and E.J.G. are employees/shareholders of Insmed. J.R.B.P. also receives research funding from GSK and consultancy fees from WW International. Y.Z. is a UK University worker at GSK. S.O. has undertaken remunerated consultancy work for Pfizer, Third Rock Ventures, AstraZeneca, NorthSea Therapeutics and Courage Therapeutics. V.S., V.T., T.O., G.T., and K.S. are employees of deCODE genetics, a subsidiary of Amgen. The remaining authors declare no competing interests.